Search

everythinglearnresearchcommunity

for

Search:↓

Understanding the genetics of rare inherited ichthyosis syndromes is key for better treatments and genetic counseling.

Nanoparticulate systems improve drug delivery by controlling release, protecting drugs, changing absorption and distribution, and concentrating drugs in targeted areas.

New alopecia treatments aim for better results and fewer side effects.

Microneedle arrays with nanotechnology show promise for painless drug delivery through the skin but need more research on safety and effectiveness.

Different types of hair loss in lupus need careful diagnosis for proper treatment.

Scalp cooling is largely ineffective in preventing hair loss from breast cancer chemotherapy.

Scalp cooling can help prevent chemotherapy-induced hair loss with a 50-90% success rate and is safe for patients.

Early diagnosis and treatment are crucial for preventing permanent hair loss in various scalp conditions, and while new treatments are promising, more research is needed to evaluate their effectiveness.

The consensus document recommends a comprehensive treatment plan for Hidradenitis Suppurativa, including various medications, surgery, lifestyle changes, and the need for more research and resources.

The new drug delivery system releases the drug better in sebum and targets follicles more effectively than the conventional cream.

Pregnancy can change skin disease severity, with some conditions improving and others worsening, and treatment should balance benefits and fetal safety.

Ion-paired risedronate significantly increases skin penetration without irritation compared to risedronate alone.

Madarosis is the loss of eyelashes and eyebrows due to various health issues and requires thorough examination to diagnose and treat the underlying cause.

Chitosan-coated nanoparticles improve skin delivery of hair loss treatments with fewer side effects.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

Teriflunomide is effective and generally safe for treating relapsing-remitting multiple sclerosis.

Oleic acid nanovesicles improve minoxidil absorption in hair follicles for alopecia treatment.

The document concludes that lifestyle changes and medical treatments can significantly reduce symptoms of Hidradenitis Suppurativa, a chronic skin condition.

The European Society of Cutaneous Lupus Erythematosus created a questionnaire to standardize patient assessment and improve care for cutaneous lupus.

New treatments for hair loss show promise, but more research is needed to confirm their safety and effectiveness.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

COVID-19 can cause various skin issues, including rashes and hair loss, which usually heal on their own and don't always indicate severe illness.

The Brazilian Society of Dermatology agrees that oral isotretinoin is effective for acne and other skin conditions, and it's safe when monitored, but more research is needed on dosing and duration.

Bimatoprost can cause longer, thicker, darker eyelashes and eyebrows.

Most hair loss disorders can be accurately diagnosed and treated in an outpatient setting.

The document concludes that clinicians should be aware of common hair and scalp disorders in women of African descent and that more research is needed to develop effective treatments.

The document says that treating the root cause of hair follicle damage is crucial to prevent permanent hair loss, and treatment options vary.

New chemotherapy drugs cause skin side effects, but treatments like minocycline and tetracycline can help reduce them.

Tamoxifen can cause total hair loss but its benefits outweigh this side effect.

The article concludes that correctly diagnosing systemic causes of hair loss requires a detailed clinical evaluation and a systematic diagnostic approach.